NPI: 1134773419 · BLOOMINGTON, MN 55425 · Clinic/Center · NPI assigned 07/25/2019
Authorized official RING, MAUREEN controls 20+ related entities in our dataset. Read more
| Authorized Official | RING, MAUREEN (SYS DIR GOVT REIMB & NETWK REL) |
| NPI Enumeration Date | 07/25/2019 |
Other providers sharing the same authorized official: RING, MAUREEN
| Provider | City | State | Total Paid |
|---|---|---|---|
| FAIRVIEW HEALTH SERVICES | MINNEAPOLIS | MN | $90.41M |
| FAIRVIEW HEALTH SERVICES | SAINT PAUL | MN | $48.52M |
| FAIRVIEW HEALTH SERVICES | BURNSVILLE | MN | $29.98M |
| FAIRVIEW HEALTH SERVICES | MINNEAPOLIS | MN | $26.56M |
| HEALTHEAST ST. JOHN'S HOSPITAL | MAPLEWOOD | MN | $17.91M |
| FAIRVIEW HEALTH SERVICES | EDINA | MN | $17.24M |
| HEALTHEAST MEDICAL RESEARCH INSTITUTE | SAINT PAUL | MN | $11.37M |
| FAIRVIEW CLINICS | BLOOMINGTON | MN | $9.40M |
| FAIRVIEW HEALTH SERVICES | PRINCETON | MN | $9.36M |
| HEALTHEAST MEDICAL RESEARCH INSTITUTE | SAINT PAUL | MN | $8.76M |
| HEALTHEAST MEDICAL RESEARCH INSTITUTE | SAINT PAUL | MN | $8.29M |
| FAIRVIEW CLINICS | BROOKLYN PARK | MN | $8.06M |
| FAIRVIEW HEALTH SERVICES | WYOMING | MN | $7.71M |
| HEALTHEAST MEDICAL RESEARCH INSTITUTE | MAPLEWOOD | MN | $7.44M |
| HEALTHEAST WOODWINDS HOSPITAL | WOODBURY | MN | $6.17M |
| FAIRVIEW CLINICS | BURNSVILLE | MN | $4.75M |
| FAIRVIEW CLINICS | MINNEAPOLIS | MN | $4.75M |
| FAIRVIEW EXPRESS CARE | SAINT PAUL | MN | $4.57M |
| FAIRVIEW CLINICS | SAINT PAUL | MN | $4.37M |
| HEALTHEAST MEDICAL RESEARCH INSTITUTE | WOODBURY | MN | $4.07M |
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 14 | $659.25 |
| 2021 | 338 | $8K |
| 2022 | 366 | $16K |
| 2023 | 374 | $21K |
| 2024 | 181 | $11K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 847 | 817 | $49K |
| 99421 | 309 | 266 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 27 | 27 | $2K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 13 | 13 | $916.72 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 33 | 32 | $771.76 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 27 | 27 | $634.01 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 17 | 16 | $548.04 |